| Sideroblastic anemias are usually associated
with microcytosis and hypochromia and thus must be distinguished from
the anemias of iron deficiency and thalassemia.
Although adequate iron is present, a mitochondrial defect (decreased
activity of D-ALA or ferrochelatase) prevents the incorporation of iron
into hemoglobin.
 |
| Instead iron accumulates in mitochondria ringing the red cell nucleus
forming "ringed sideroblasts".
Most sideroblastic anemias are acquired and are associated with drugs
(alcohol*, isoniazid, chloramphenicol, cytotoxic agents, and other Vit
B6 antagonists), heavy metals (lead), and various hematologic, neoplastic
and inflammatory diseases.
*Ethanol abuse is the most common cause. |
| 
|
| Non-heme iron accumulates in RBC mitochondria surrounding
the nucleus instead of cytoplasmic ferritin. A ring of iron is
seen as opposed to the normal situation where only a few (<4)
small aggregates of iron (ferritin) are present. |
|
| Sideroblastic anemias may be either hereditary or acquired.
The hereditary form is an X-linked recessive trait with variable expression.
Hereditary sideroblastic anemias are usually microcytic/hypochromic
and thus must be distinguished from iron deficiency and thalassemia.
Anisocytosis (increased RDW) due to microcytic and normocytic RBCs
and basophilic stippling are common.
Because iron is not being used transferrin saturation is elevated (>80%)
and serum LDH is increased (ineffective erythropoiesis). |

|
| Acquired sideroblastic anemia is often the earliest evidence
of a myelodysplastic syndrome (MDS) - refractory anemia with ringed
sideroblasts. The ringed sideroblasts of MDS are accompanied by dysplasia
of myeloid and megakaryoctic cell lines and should be classified as
one of the myelodysplastic syndromes. See White Cell Disorder Section.
Acquired sideroblastic anemia frequently demonstrates a "dimorphic"
RBC population [microcytic and macrocytic RBCs (increased RDW)],
basophilic stippling, ovalocytes, and other evidence of poikilocytosis. |

|